Immediate Impact

84 standout
Sub-graph 1 of 21

Citing Papers

Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?
2019 Standout
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
2018 Standout
2 intermediate papers

Works of Michael Kontos being referenced

In silico/in vitro study of hybrid D-modified steroidal alkylator anticancer activity using uridine phosphorylase as target protein.
2011
Evaluation of the Emergency Eepartment Chest Pain Patient
2001

Author Peers

Author Last Decade Papers Cites
Michael Kontos 338 334 166 307 55 1.1k
Laurent Sebbag 299 470 69 133 64 1.2k
Marvin G. Chang 350 308 180 71 57 1.0k
Aurélie Mailhac 649 404 295 90 60 1.4k
Yan Zhao 321 399 139 132 76 995
Laurence A. Sherman 207 336 440 100 45 1.4k
H. Vernhet 300 318 384 103 53 1.4k
Nikolaos Karkavitsas 255 205 246 139 34 979
Philip Lewis 134 407 37 184 60 898
G M Hutchins 300 227 472 129 34 1.2k
Jan Larmann 252 269 89 57 61 939

All Works

Loading papers...

Rankless by CCL
2026